FI71314C - Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt - Google Patents

Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt Download PDF

Info

Publication number
FI71314C
FI71314C FI821324A FI821324A FI71314C FI 71314 C FI71314 C FI 71314C FI 821324 A FI821324 A FI 821324A FI 821324 A FI821324 A FI 821324A FI 71314 C FI71314 C FI 71314C
Authority
FI
Finland
Prior art keywords
calcium
diphenyloxazol
propionsyrakalciumsalt
framework
procedure
Prior art date
Application number
FI821324A
Other languages
English (en)
Finnish (fi)
Other versions
FI821324A0 (fi
FI821324L (fi
FI71314B (fi
Inventor
Ahmed Saeed Mughal
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of FI821324A0 publication Critical patent/FI821324A0/fi
Publication of FI821324L publication Critical patent/FI821324L/fi
Publication of FI71314B publication Critical patent/FI71314B/fi
Application granted granted Critical
Publication of FI71314C publication Critical patent/FI71314C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI821324A 1981-04-28 1982-04-15 Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt FI71314C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8113074 1981-04-28
GB8113074 1981-04-28

Publications (4)

Publication Number Publication Date
FI821324A0 FI821324A0 (fi) 1982-04-15
FI821324L FI821324L (fi) 1982-10-29
FI71314B FI71314B (fi) 1986-09-09
FI71314C true FI71314C (fi) 1986-12-19

Family

ID=10521427

Family Applications (1)

Application Number Title Priority Date Filing Date
FI821324A FI71314C (fi) 1981-04-28 1982-04-15 Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt

Country Status (24)

Country Link
US (2) US4465838A (pl)
EP (1) EP0063884B1 (pl)
JP (1) JPS57181072A (pl)
KR (1) KR880000871B1 (pl)
AT (1) ATE14015T1 (pl)
AU (1) AU544975B2 (pl)
CA (1) CA1169867A (pl)
CS (1) CS236674B2 (pl)
DD (1) DD202017A5 (pl)
DE (1) DE3264400D1 (pl)
DK (1) DK150604C (pl)
ES (1) ES511730A0 (pl)
FI (1) FI71314C (pl)
GR (1) GR75913B (pl)
HU (1) HU185276B (pl)
IE (1) IE52909B1 (pl)
IL (1) IL65443A (pl)
MY (1) MY8700599A (pl)
NZ (1) NZ200247A (pl)
PH (1) PH18053A (pl)
PL (1) PL136322B1 (pl)
PT (1) PT74794B (pl)
ZA (1) ZA822355B (pl)
ZW (1) ZW7482A1 (pl)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380738A (en) * 1993-05-21 1995-01-10 Monsanto Company 2-substituted oxazoles further substituted by 4-fluorophenyl and 4-methylsulfonylphenyl as antiinflammatory agents
US6726928B2 (en) * 1994-10-28 2004-04-27 R.P. Scherer Technologies, Inc. Process for preparing solid dosage forms for unpalatable pharmaceuticals
KR20000015865A (ko) * 1996-05-20 2000-03-15 윌리암스 로저 에이 칼륨, 나트륨 및 트리스옥사프로진염의 약학적 제제
US7358254B2 (en) * 2001-07-13 2008-04-15 Bristol-Myers Squibb Company Method for treating atherosclerosis employing an aP2 inhibitor and combination
US20060251689A1 (en) * 2005-03-30 2006-11-09 Astion Development A/S Treatment or prevention of pruritus
AU2006228869A1 (en) * 2005-03-30 2006-10-05 Astion Pharma A/S Oxaprozin or a closely related compound for the treatment of eczema
WO2010023621A2 (en) * 2008-08-26 2010-03-04 Dorf Ketal Chemicals (I) Pvt. Ltd. A new additive for inhibiting acid corrosion and method of using the new additive
KR20140065862A (ko) * 2012-11-22 2014-05-30 에스케이케미칼주식회사 발포성 속붕해성 이매티닙 제제

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1206403A (en) * 1966-12-15 1970-09-23 Wyeth John & Brother Ltd Oxazoles
GB1245087A (en) * 1967-10-26 1971-09-02 Wyeth John & Brother Ltd Heterocyclic compounds
US3578671A (en) * 1967-11-06 1971-05-11 Wyeth John & Brother Ltd Oxazoles

Also Published As

Publication number Publication date
DD202017A5 (de) 1983-08-24
AU544975B2 (en) 1985-06-27
EP0063884A1 (en) 1982-11-03
PH18053A (en) 1985-03-18
AU8237882A (en) 1982-11-04
NZ200247A (en) 1984-10-19
IL65443A (en) 1985-04-30
IE820766L (en) 1982-10-28
JPS57181072A (en) 1982-11-08
ZW7482A1 (en) 1983-11-09
DK150604B (da) 1987-04-13
IL65443A0 (en) 1982-07-30
ES8307230A1 (es) 1983-07-01
FI821324A0 (fi) 1982-04-15
ES511730A0 (es) 1983-07-01
KR880000871B1 (ko) 1988-05-28
PL136322B1 (en) 1986-02-28
JPH0261466B2 (pl) 1990-12-20
PT74794B (en) 1983-11-07
FI821324L (fi) 1982-10-29
EP0063884B1 (en) 1985-06-26
FI71314B (fi) 1986-09-09
US4532253A (en) 1985-07-30
DK150604C (da) 1987-12-07
ZA822355B (en) 1983-11-30
CA1169867A (en) 1984-06-26
DK183582A (da) 1982-10-29
ATE14015T1 (de) 1985-07-15
US4465838A (en) 1984-08-14
HU185276B (en) 1984-12-28
PL236145A1 (pl) 1982-12-06
GR75913B (pl) 1984-08-02
MY8700599A (en) 1987-12-31
KR830009772A (ko) 1983-12-23
PT74794A (en) 1982-05-01
DE3264400D1 (en) 1985-08-01
IE52909B1 (en) 1988-04-13
CS236674B2 (en) 1985-05-15

Similar Documents

Publication Publication Date Title
FI71314B (fi) Foerfarande foer framstaellning av en terapeutiskt anvaendbar beta-(4,5-difenyloxazol-2-yl) propionsyrakalciumsalt
US4073895A (en) Isopropylamino pyrimidine orthophosphate
JPS59148789A (ja) 高度に結晶性のナトリウムセフオペラゾンの製法
US3028420A (en) Compound of betaine and chloral and method for preparing same
KR880002289B1 (ko) 2-아미노-3-(할로벤조일)-메틸페닐아세트산 및 그 유도체의 제조방법
RU2126402C1 (ru) Способ селективного получения 3/2 гидрата 7-[(7-(s)-амино-5-азаспиро [2,4] гептан- 5-ил]-8-хлор-6-фтор-1- [(1r, 2s)-2-фторциклопропил]-4-оксо-1,4-дегидрохинолин-3- карбоновой кислоты, безводная 7-[(7-(s)-амино-5-азаспиро [2,4] гептан-5-ил]-8-хлор-6- фтор-1- (1r, 2s)-2-фторциклопропил-4-оксо-1,4-дигидрохинолин-3-карбоновая кислота и фармацевтическая композиция, обладающая антибактериальной активностью
EP0773783B1 (en) Preparation of fusidic acid tablets
DE1670389A1 (de) Neue quaternaere 5-Ammonium-methyl-4-amino-pyrimidinsalzverbindungen
CA1132562A (en) Halogeno derivatives of isopropylamino pyrimidine, their preparation and therapeutic use
EP0058079B1 (en) 4-(1-imidazolylmethyl)cinnamic acid hydrochloride monohydrate, method of preparation thereof, and pharmaceutical composition containing same
NO771828L (no) 3,5,5-trimetylheksanoyl-ferrocen og fremgangsm}te til dets fremstilling
JPS604189B2 (ja) 抗菌剤およびその製法
US3905959A (en) Process for the manufacture of crystalline anhydrous ampicillin
DE2706841C2 (pl)
JPS62294616A (ja) 抗真菌用薬剤
GB2054556A (en) Preparation of hydroxy derivatives of 2-isopropylamino-pyrimidine
KR100257967B1 (ko) 피리독신 5-옥소-2-피롤리돈 카르복실레이트의 제조공정
JPS5626709A (en) Manufacture of water soluble iron salt
US6271397B1 (en) L-ascorbic acid-2-phosphoric acid potassium crystal and method for producing the same
GB2097389A (en) Oxazole derivative
US2478984A (en) Medicinal preparation containing available calcium and phosphorus
US3644395A (en) Phenylbutazone-sodium-monoglycerate
JPH0315632B2 (pl)
HU196166B (en) Process for producing new guandinium-asparaginate derivatives and pharmaceutical compositions containing them
EP0153171A2 (en) New 2-hydroxyethyl-trimethylammonium salt of 1-ethyl-3-carboxy-4-oxo-6,7-methylenedioxy-1,4-dihydroquinoline, process for the preparation thereof and pharmaceutical composition containing it

Legal Events

Date Code Title Description
MA Patent expired

Owner name: JOHN WYETH & BROTHER LIMITED